HOME Research Insight Intuitive Surgical, Inc. Dominated the Global Medical Robots Market in 2015

Intuitive Surgical, Inc. Dominated the Global Medical Robots Market in 2015

A number of key players are competing against each other to expand their existing customer base. In 2015, the global medical robot instruments and accessories market was dominated by Intuitive Surgical, Inc. (U.S.) and Stryker Corporation (U.S.). These companies jointly accounted for a share of ~94.3%. Furthermore, the surgical robot systems market was dominated by Intuitive Surgical, Inc. (U.S.), Stryker Corporation (U.S.), Mazor Robotics Ltd. (Israel), and Hansen Medical, Inc. (a wholly owned subsidiary of Auris Surgical Robotics) (U.S.). These companies jointly accounted for a share of ~95%.

Various players operating in the medical robots market include Hocoma AG (Switzerland), Accuray Incorporated (U.S.), Omnicell, Inc. (U.S.), ARxIUM (Canada), Ekso Bionics Holdings, Inc. (U.S.), and Kirby Lester LLC (U.S.)

In 2015, Intuitive Surgical, Inc. (U.S.) accounted for a share of ~88.8% in the global surgical robots market. The company has a special focus on the laparoscopic surgical robots market segment. Continuous advancements in its robotic systems have helped the company maintain a strong leadership position in the market. The company has three premium robotic systems—da Vinci Xi, da Vinci Si, and da Vinci Surgical System. As of 2015, the company had 3,597 systems installed worldwide, an increase compared to 3,266 systems in 2014. Additionally, the company focuses on gaining regulatory approvals for its systems and accessories in order to enter different regional markets. For instance, in June 2014, Intuitive Surgical, Inc. received the CE Mark for its da Vinci Xi Surgical System.

Hocoma AG (Switzerland) is a major player in the global rehabilitation robots market. The company works closely with research centers and leading clinics to develop innovative therapy solutions. The broad product portfolio of the company comprises of Armeo Therapy Concept, Erigo, Lokomat, and Valdeo Therapy Concept. Launching new products has been the dominant strategy adopted by the company. In July 2015, the company launched ArmeoPower, an exoskeleton for integrated arm and hand rehabilitation. This device enabled stroke-affected patients to use their hands and arms. With a whole suite of technologically advanced products, the company has a wide customer base amongst rehabilitation centers. The company’s Lokomat Pro is a popular therapeutic robot that provides effective gait training for stroke patients at rehabilitation centers worldwide.

In 2015, Accuray Incorporated (U.S.) accounted for a share of ~66% in the global noninvasive radiological surgical robots market. The company’s CyberKnife Robotic Radiosurgery System is one of the most commonly used radiosurgical robotic system. The company majorly focuses on participating in marketing and promotion activities to showcase its products. For instance, in September 2016, Accuray participated in 2016 ASTRO (American Society for Radiation Oncology) Annual Meeting held in Boston (U.S.). In the meeting, Accuray showcased its new Radixact System and a treatment planning software. Leading radiation oncology practitioners in the meeting also shared new data on the Accuray’s CyberKnife and TomoTherapy Systems.

Other players operating in this market adopted the strategy of collaborations, contracts, agreements, partnerships, acquisitions, expansions, product launches, grants, patents, and licensing to increase their customer base across geographies and establish a strong foothold in the market.

Related Reports:

Medical Robots Market by Product (Instruments & Accessories and Robot Systems (Surgical Robots, Rehabilitation Robots, Hospital Robots, Non-invasive Surgery Robots)), Application (Orthopedic, Laparoscopy, Neurology) - Global Forecasts to 2021

UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports